Sapporo Clinical Laboratory Inc.

TSE:9776 Stock Report

Market Cap: JP¥3.1b

Sapporo Clinical Laboratory Management

Management criteria checks 2/4

Sapporo Clinical Laboratory's CEO is Tadamasa Date, appointed in Jun 2022, has a tenure of 2.75 years. directly owns 1.99% of the company’s shares, worth ¥62.43M. The average tenure of the management team and the board of directors is 2.8 years and 8.8 years respectively.

Key information

Tadamasa Date

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2.8yrs
CEO ownership2.0%
Management average tenure2.8yrs
Board average tenure8.8yrs

Recent management updates

Recent updates

Be Wary Of Sapporo Clinical Laboratory (TSE:9776) And Its Returns On Capital

Aug 06
Be Wary Of Sapporo Clinical Laboratory (TSE:9776) And Its Returns On Capital

Sapporo Clinical Laboratory's (TSE:9776) Weak Earnings May Only Reveal A Part Of The Whole Picture

May 21
Sapporo Clinical Laboratory's (TSE:9776) Weak Earnings May Only Reveal A Part Of The Whole Picture

Sapporo Clinical Laboratory (TYO:9776) Is Reinvesting At Lower Rates Of Return

Mar 29
Sapporo Clinical Laboratory (TYO:9776) Is Reinvesting At Lower Rates Of Return

Sapporo Clinical Laboratory (TYO:9776) Shareholders Have Enjoyed A 47% Share Price Gain

Feb 11
Sapporo Clinical Laboratory (TYO:9776) Shareholders Have Enjoyed A 47% Share Price Gain

Should You Use Sapporo Clinical Laboratory's (TYO:9776) Statutory Earnings To Analyse It?

Dec 24
Should You Use Sapporo Clinical Laboratory's (TYO:9776) Statutory Earnings To Analyse It?

CEO

Tadamasa Date (52 yo)

2.8yrs

Tenure

Mr. Tadamasa Date had serves as President and Representative Director at Sapporo Clinical Laboratory Inc. since June 2022. He been Vice President and General Manager of Sales at Sapporo Clinical Laboratory...

Leadership Team

NamePositionTenureCompensationOwnership
Tadamasa Date
President & Representative Director2.8yrsno data1.99%
¥ 62.4m
Akihisa Shoji
Manager of Accounting Department and Executive Officerno datano datano data
Haruo Furusaki
Executive Officer no datano datano data
Yoshihito Shoji
MD, GM of General Affairs Division & Sales Division and Director7.8yrsno datano data
Hideo Nagano
Deputy GM of Sales Divisionno datano data0.064%
¥ 2.0m
Satoru Arai
Executive VP & Director2.8yrsno datano data
Osamu Hirata
Independent Officer & External Auditorno datano datano data

2.8yrs

Average Tenure

61yo

Average Age

Experienced Management: 9776's management team is considered experienced (2.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Tadamasa Date
President & Representative Director23.8yrsno data1.99%
¥ 62.4m
Yoshihito Shoji
MD, GM of General Affairs Division & Sales Division and Director7.8yrsno datano data
Hideo Nagano
Deputy GM of Sales Division4.8yrsno data0.064%
¥ 2.0m
Satoru Arai
Executive VP & Director2.8yrsno datano data
Osamu Hirata
Independent Officer & External Auditor9.8yrsno datano data
Chuichi Date
Chairman of the Board10.8yrsno data4.04%
¥ 126.9m
Yoshiaki Kanagi
External Auditor16.8yrsno data0.064%
¥ 2.0m
Toshiyasu Miyamori
Full-time Corporate Auditor & Supervisory Board Member5.8yrsno datano data

8.8yrs

Average Tenure

66.5yo

Average Age

Experienced Board: 9776's board of directors are considered experienced (8.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/22 13:57
End of Day Share Price 2025/03/21 00:00
Earnings2024/12/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sapporo Clinical Laboratory Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Masao YoshidaIchiyoshi Research Institute Inc.